Adjuvant Endocrine Therapy In Premenopausal Breast Cancer: 12-Year Results From Soft

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

12-year follow-up of SOFT and TEXT trials

Session 9: Adjuvant endocrine therapy for premenopausal women: Risk stratification, type & duration

Endocrine therapy in premenopausal women with HR+ breast cancer

How to use endocrine therapy in premenopausal women with ER+ early breast cancer

European Society for Medical Oncology (ESMO)

Education Session: Trends in Adjuvant Endocrine Therapy

San Antonio Breast Cancer Symposium

Adjuvant endocrine therapy for breast cancer: optimal durations and regimens

Dr. Hershman on the Use of Endocrine Therapy in Premenopausal HR+/HER2- Breast Cancer

How to use endocrine therapy in premenopausal women with ER+ metastatic breast cancer

European Society for Medical Oncology (ESMO)

Adjuvant Therapy | 2023 KU Breast Cancer Year in Review Conference

Total Health | Oncology

Dr. Rao on the SOFT Trial in Patients With Premenopausal Breast Cancer

Adjuvant endocrine therapy in postmenopausal women: Risk stratification, type & duration

Adjuvant Therapy | 2023 Best of Breast Conference

Total Health | Oncology

Determining Endocrine Therapy for Premenopausal Breast Cancer Patients: Practical Considerations

Adjuvant exemestane more effective than tamoxifen (combined with ofs) in women with breast cancer

Evaluating endocrine therapy in pre-menopausal women with breast cancer

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy

Total Health | Oncology

Combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppression

Dr. Prudence Francis | Premenopausal ER+ Breast Cancer: Past, Present, Future | SABCS 2022

San Antonio Breast Cancer Symposium

Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures

Total Health | Oncology